109971 ⎘
dsDNA viruses; Details; Polyomaviridae, e.g. polyoma, SV40, JC New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
CHIMERIC INVASIN SYSTEM
#2FUSION PROTEIN FOR INDUCING IMMUNE RESPONSE AND TREATING CANCER
#3PERSON-TAILORED T CELL COMPOSITION TARGETING MERKEL CELL CARCINOMA
#4ACTIVE DELIVERY OF NUCLEIC ACIDS AND PEPTIDES, METHODS AND USES
#5IMMUNOTHERAPY FOR POLYOMAVIRUSES
#6A METHOD FOR PROVIDING A VLP DERIVED FROM JOHN CUNNINGHAM VIRUS
#7ARTIFICIAL VIRUS PRESENTING CELLS
#8Nucleic acid origami structure encapsulated by capsid units
#9INHIBITION OF INNATE IMMUNE RESPONSE
#10Recombinant vector comprising porcine FC fragment and preparation method of recombinant protein using thereof
#11Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#12Retargeting of viruses or VLPs
#13Drug delivery system based on JCV-VLP
#14Conjugates enhancing total cellular accumulation
#15Vectors and host cells comprising a modified SV40 promoter for protein expression
#16Methods and compositions for integration defective lentiviral vectors
#17Inhibition of innate immune response
#18NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP
#19Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#20JC polyomavirus VLP (virus-like particle) with a targeting peptide
#21VLP WITH A FUSION PROTEIN
#22Immortalized cell
#23Vectors and host cells comprising a modified SV40 promoter for protein expression
#24POLYOMAVIRUS PEPTIDE SEQUENCES
#25Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#26Antibody molecules
#27A NOVEL DRUG DELIVERY SYSTEM BASED ON JCV-VLP
#28Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#29Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
#30Immunogenic compositions and methods therefor
#31Inhibition of innate immune response
#32Method for preparing human neoplastically transformed cells
#33Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles
#34Antibody molecules
#35Method for preparing human neoplastically transformed cells
#36TRANSIENT IMMORTALIZATION
#37Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#38METHOD FOR THE EXPRESSION OF A RECOMBINANT PROTEIN IN A MAMMALIAN CELL
#39METHOD OF PREPARATION OF A BIOLOGICAL PARTICULATE STRUCTURE
#40CONSTRUCT COATED WITH VIRUS COAT-CONSTITUTING PROTEIN AND METHOD FOR PRODUCING SAME
#41Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles
#42FULL LENGTH LARGE T TUMOR ANTIGEN OF MERKEL CELL POLYOMAVIRUS AS A THERAPEUTIC TARGET IN MERKEL CELL CARCINOMA
#43Human polyomavirus, designated the wu virus, obtained from human respiratory secretions
#44Viral particle-like structure in physiological conditions, and method of forming it
#45Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
#46MELAN-A-CARRIER CONJUGATES
#47Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
#48Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
#49Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
#50VLP based vaccine delivery system
#51ALTERED VIRUS CAPSID PROTEIN AND USE THEREOF
#52Process for the production of monoclonal antibodies
#53IMMORTALIZATION OF MAMMALIAN CELLS
#54Method for Producing Virus-Type Particles Containing an Active Substance
#55Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
#56Expression system for enhancing solubility and immunogeneicity of recombinant proteins
#57EVALUATING IMMUNE COMPETENCE
#58Expression system for enhancing solubility and immunogeneicity of recombinant proteins
#59Frizzled proteins and detection and treatment of cancer
#60Virus-like particles for the induction of autoantibodies
#61Viral Particle-Like Construct and Method of Forming the Same Under Physiological Conditions
#62Immortalization of Mammalian Cells
#63Transient immortalization
#64Antigens
#65Methods of obtaining neural stem cells
#66Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances
#67Method for linking molecular substances
#68Virus-like particles for the induction of autoantibodies
#69Melan-A- carrier conjugates
#70Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
#71Method of cell growth inhibition with agnoprotein
#72Modular transport systems for molecular substances and production and use thereof
#73Transient immortalization
#74Mammalian expression system
#75Reversible immortalization of human renal proximal tubular epithelial cells
#76Diagnosing and treating cancer cells using mutant viruses